πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Vera Therapeutics Patents

Full USPTO pharma patent portfolio for Vera Therapeutics β€” grant dates, expiration, and drug cross-links.

Patents
140
Expiring ≀24m
2

Quick answer

Vera Therapeutics has 140 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months β€” use filters for patent-cliff planning.

Page 2 of 3

  1. US 10940208

    Nanoassembled complexes of nucleic acids, avidin and biotinylated compounds for use as drug carriers

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10927362

    Processable single chain molecules and polypeptides made using same

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10898554

    Factor IX polypeptides and methods of use thereof

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10881742

    Factor VIII chimeric and hybrid polypeptides, and methods of use thereof

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10857161

    Non-hormonal steroid modulators of NF-kB for treatment of disease

    Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10799514

    Non-hormonal steroid modulators of NF-kappa beta for treatment of disease

    Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10799713

    Miniature wearable laser treatment device

    Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10786554

    Factor VIII polypeptide formulations

    Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10772942

    Lyophilized factor IX formulations

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10751343

    Nasal compositions stimulating ciliary activity

    Expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10745680

    Factor IX fusion proteins and methods of making and using same

    Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10729767

    Humanized anti-C1s antibodies and methods of inhibiting C1s cleavage

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10731116

    Alcoholic compositions having a lowered risk of acetaldehydemia

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10631559

    Acidic extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-(3S,6S)-

    Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10588949

    Factor IX polypeptide formulations

    Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10584147

    Procoagulant fusion compound

    Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10568943

    Factor IX polypeptides and methods of use thereof

    Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10561714

    Factor IX polypeptides and methods of use thereof

    Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10548954

    Factor IX polypeptides and methods of use thereof

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10548953

    Factor VIII-XTEN fusions and uses thereof

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10532079

    Extracts and beverages containing 2,5-piperazinedione, 3,6-bis(phenylmethyl)-, (3S,6S)-

    Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10532056

    Therapeutic compositions, combinations, and methods of use

    Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10526655

    Methods for evaluating COPD status

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10499682

    Micronutrient formulation in electronic cigarettes

    Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10494316

    Process for the preparation of deuterated ethanol from D2O

    Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10464967

    Non-hormonal steroid modulators of NF-ΞΊΞ² for treatment of disease

    Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10457745

    Anti-complement C1s antibodies

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10450382

    Anti-complement C1s antibodies

    Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10421798

    Factor VIII compositions and methods of making and using same

    Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10406158

    Methods and compositions for treating abnormal cell growth

    Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10391152

    Methods of using a fixed dose of a clotting factor

    Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10370430

    Recombinant factor VIII proteins

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10325687

    Population pharmacokinetics tools and uses thereof

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10308909

    Dried spore germinative compound mixtures

    Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10287564

    Procoagulant compounds

    Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10221455

    Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy

    Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10206933

    Non-hormonal steroid modulators of NF-kB for treatment of disease

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10202595

    Chimeric clotting factors

    Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10138291

    Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof

    Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10080379

    Zinc and copper fortifying composition, a hydrating supplement, and process for preparing the same

    Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10047330

    Alcoholic compositions having a lowered risk of acetaldehydemia

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10023628

    Cell line expressing single chain factor VIII polypeptides and uses thereof

    Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10010622

    Factor VIII chimeric and hybrid polypeptides, and methods of use thereof

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10005670

    Calcium polyphosphate salt particles and method of making

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10001495

    Blood factor monitoring assay and uses thereof

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10000525

    Non-hormonal steroid modulators of NF-ΞΊB for treatment of disease

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9962385

    Methods and compositions for treating abnormal cell growth

    Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9932543

    Bacterial spore compositions for industrial uses

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Vera Therapeutics have?

140 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Vera Therapeutics patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.